Condition

Glutaric aciduria type 1

Endocrine, Nutritional and Metabolic Diseases

Glutaric aciduria type 1, also called glutaric acidemia type 1 and abbreviated GA1, is an inherited metabolic disorder in which the body cannot completely break down the amino acids lysine, hydroxylysine and tryptophan. Intermediate products of that breakdown, including glutaric acid, glutaryl-CoA, 3-hydroxyglutaric acid and glutaconic acid, accumulate and can damage the brain, particularly the basal ganglia, the regions that help regulate movement, and other organs as well. Because glutaric acid is detoxified by carnitine, the condition also causes a secondary carnitine deficiency, and intellectual disability may occur. GA1 is inherited in an autosomal recessive pattern and is caused by a deficiency of the enzyme glutaryl-CoA dehydrogenase, which is encoded by the GCDH gene.

Facts
Classification
Body System
Nervous System 1
ICD-10 Chapter
IV: Endocrine, Nutritional and Metabolic Diseases 2
Communicable or Non-communicable
Non-Communicable 3
Transmission Route
Non-Transmissible 1
Causative Agent
Causative Agent (category)
Genetic / Hereditary 1
Prevalence Band
Rare (Under 1 in 2000) 4
Sources
1. Glutaric aciduria type 1 (Wikipedia)
  • Lead paragraph 1
    can accumulate and cause damage to the brain (and also other organs), but particularly the basal ganglia
  • Lead paragraph 2
    GA1 is an autosomal recessive disorder caused by deficiency of the enzyme glutaryl-CoA dehydrogenase (GCDH), encoded by the GCDH gene.
  • Lead
    Glutaric acidemia type 1 (GA1) is an inherited disorder in which the body is unable to completely break down the amino acids lysine, hydroxylysine and tryptophan.
View the Source
2. Orphadata (Orphanet): Orphadata cross-references for ORPHA:25 Glutaric aciduria type 1
Orphadata (Orphanet)ICD-10 cross-reference
Quote, ICD-10 cross-reference
"Reference": "E72.3", "Source": "ICD-10"
View the Source
3. Monarch Initiative: glutaryl-CoA dehydrogenase deficiency - Monarch Initiative MONDO:0009281
Monarch InitiativeDisease description
Quote, Disease description
Glutaryl-CoA dehydrogenase (GCDH) deficiency (GDD) is an autosomal recessive neurometabolic disorder clinically characterized by encephalopathic crises resulting in striatal injury and a severe dystonic dyskinetic movement disorder.
View the Source
4. Orphadata (Orphanet): Orphadata epidemiology for ORPHA:25 Glutaryl-CoA dehydrogenase deficiency
Orphadata (Orphanet)Prevalence, Worldwide
Quote, Prevalence, Worldwide
"PrevalenceClass": "1-9 / 100 000", "PrevalenceGeographic": "Worldwide"
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.

Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme